Efroze launches drugs in Nigeria

Efroze Chemical Industries, a leading Pakistani drugmaker, has introduced a range of its products to the Nigerian market to compete with existing brands in the country. Speaking at a joint press conference in the Nigerian capital of Lagos, Gbola Adebisi, managing director of FAB Medicals which is the sole distributor of the products, said they had all undergone and passed the National Agency for Foods, Drugs Administration and Control's requirements for sale in Nigeria.

Among the products, which Mr Adebisi said could compete anywhere in the world in terms of quality, are Roxin (bavofloxacin) antibiotic tablets, Erizole (mebendazole) anthelmintic tablets and suspension, Efrodar (pyrimethamine and sulfadoxine) antimalarial tablets and Gynaecosid (methyloestenolene/estradiol) hormone tablets.

Also speaking at this event, Efroze export manager Jaffer Dadabhais claimed that his company was already exporting its products to 17 countries spread across Africa, the Middle East and the Russian Federation.